Description
Research overview
Sermorelin corresponds to the amidated 1–29 fragment of growth hormone-releasing hormone. Experimental studies have investigated the structural requirements of GHRH-derived peptides for biological activity.
Evidence context
The referenced work examines peptide structure and pharmacology. It does not establish clinical suitability or performance of an Anykuu research batch.
Material identity
Confirm the GHRH (1–29)-amide sequence, salt form, and analytical identity. Sermorelin and modified GRF (1–29) are not interchangeable names.
Specifications & documentation
Pack sizes, purity, storage conditions, and batch COA await supplier confirmation.
Research reference
Structure-activity study of hGHRH (1–29)-amide
For laboratory research use only. Not for human or veterinary use.






Reviews
There are no reviews yet.